Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination

HCV Bũdingen, N Tanuma, P Villoslada… - Journal of clinical …, 2001 - Springer
HCV Bũdingen, N Tanuma, P Villoslada, JC Ouallet, SL Hauser, CP Genain
Journal of clinical immunology, 2001Springer
Myelin/oligodendrocyte glycoprotein (MOG) is a surface-exposed antigen of myelin and an
important target for autoimmune responses which mediate inflammatory demyelination in
the central nervous system. Experimentally, MOG induces strong pathogenic T cell
responses in many strains of laboratory animals. Immunological studies in humans also
identify MOG as a surprisingly prevalent antigenic molecule among the myelin proteins. In
addition, the encephalitogenic properties of MOG are linked to the induction of antibody …
Abstract
Myelin/oligodendrocyte glycoprotein (MOG) is a surface-exposed antigen of myelin and an important target for autoimmune responses which mediate inflammatory demyelination in the central nervous system. Experimentally, MOG induces strong pathogenic T cell responses in many strains of laboratory animals. Immunological studies in humans also identify MOG as a surprisingly prevalent antigenic molecule among the myelin proteins. In addition, the encephalitogenic properties of MOG are linked to the induction of antibody responses which have been demonstrated to directly promote central nervous system demyelination, a hallmark neuropathological feature in disorders such as human multiple sclerosis. Factors responsible for autoimmunity to MOG likely include genetic influences as well as other mechanisms, which are the subject of intense investigation. This article reviews experimental data currently available on specificity and pathogenic roles of T cell and antibody responses against MOG, which have implications relevant to multiple sclerosis and related disorders.
Springer